Cargando…
Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
Hypertensive disorders of pregnancy (HDP), such as gestational hypertension and pre-eclampsia, affect up to 10% of all pregnancies. These women have on average a twofold higher risk to develop cardiovascular disease (CVD) later in life as compared with women with normotensive pregnancies. This incre...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678044/ https://www.ncbi.nlm.nih.gov/pubmed/31175138 http://dx.doi.org/10.1136/heartjnl-2018-313453 |
_version_ | 1783441007215378432 |
---|---|
author | Benschop, Laura Duvekot, Johannes J Roeters van Lennep, Jeanine E |
author_facet | Benschop, Laura Duvekot, Johannes J Roeters van Lennep, Jeanine E |
author_sort | Benschop, Laura |
collection | PubMed |
description | Hypertensive disorders of pregnancy (HDP), such as gestational hypertension and pre-eclampsia, affect up to 10% of all pregnancies. These women have on average a twofold higher risk to develop cardiovascular disease (CVD) later in life as compared with women with normotensive pregnancies. This increased risk might result from an underlying predisposition to CVD, HDP itself or a combination of both. After pregnancy women with HDP show an increased risk of classical cardiovascular risk factors including chronic hypertension, renal dysfunction, dyslipidemia, diabetes and subclinical atherosclerosis. The prevalence and onset of cardiovascular risk factors depends on the severity of the HDP and the coexistence of other pregnancy complications. At present, guidelines addressing postpartum cardiovascular risk assessment for women with HDP show a wide variation in their recommendations. This makes cardiovascular follow-up of women with a previous HDP confusing and non-coherent. Some guidelines advise to initiate cardiovascular follow-up (blood pressure, weight and lifestyle assessment) 6–8 weeks after pregnancy, whereas others recommend to start 6–12 months after pregnancy. Concurrent blood pressure monitoring, lipid and glucose assessment is recommended to be repeated annually to every 5 years until the age of 50 years when women will qualify for cardiovascular risk assessment according to all international cardiovascular prevention guidelines. |
format | Online Article Text |
id | pubmed-6678044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-66780442019-08-16 Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy Benschop, Laura Duvekot, Johannes J Roeters van Lennep, Jeanine E Heart Review Hypertensive disorders of pregnancy (HDP), such as gestational hypertension and pre-eclampsia, affect up to 10% of all pregnancies. These women have on average a twofold higher risk to develop cardiovascular disease (CVD) later in life as compared with women with normotensive pregnancies. This increased risk might result from an underlying predisposition to CVD, HDP itself or a combination of both. After pregnancy women with HDP show an increased risk of classical cardiovascular risk factors including chronic hypertension, renal dysfunction, dyslipidemia, diabetes and subclinical atherosclerosis. The prevalence and onset of cardiovascular risk factors depends on the severity of the HDP and the coexistence of other pregnancy complications. At present, guidelines addressing postpartum cardiovascular risk assessment for women with HDP show a wide variation in their recommendations. This makes cardiovascular follow-up of women with a previous HDP confusing and non-coherent. Some guidelines advise to initiate cardiovascular follow-up (blood pressure, weight and lifestyle assessment) 6–8 weeks after pregnancy, whereas others recommend to start 6–12 months after pregnancy. Concurrent blood pressure monitoring, lipid and glucose assessment is recommended to be repeated annually to every 5 years until the age of 50 years when women will qualify for cardiovascular risk assessment according to all international cardiovascular prevention guidelines. BMJ Publishing Group 2019-08 2019-06-07 /pmc/articles/PMC6678044/ /pubmed/31175138 http://dx.doi.org/10.1136/heartjnl-2018-313453 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Benschop, Laura Duvekot, Johannes J Roeters van Lennep, Jeanine E Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy |
title | Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy |
title_full | Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy |
title_fullStr | Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy |
title_full_unstemmed | Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy |
title_short | Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy |
title_sort | future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678044/ https://www.ncbi.nlm.nih.gov/pubmed/31175138 http://dx.doi.org/10.1136/heartjnl-2018-313453 |
work_keys_str_mv | AT benschoplaura futureriskofcardiovasculardiseaseriskfactorsandeventsinwomenafterahypertensivedisorderofpregnancy AT duvekotjohannesj futureriskofcardiovasculardiseaseriskfactorsandeventsinwomenafterahypertensivedisorderofpregnancy AT roetersvanlennepjeaninee futureriskofcardiovasculardiseaseriskfactorsandeventsinwomenafterahypertensivedisorderofpregnancy |